Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients

Ho Sheng Wu, Yueh Chun Hsieh, Ih Jen Su, Ting Hsiang Lin, Shu Chun Chiu, Yu Fen Hsu, Jih Hui Lin, Mei Ching Wang, Jeou Yuan Chen, Pei Wen Hsiao, Geen Dong Chang, Andrew H J Wang, Hsien Wei Ting, Chih Ming Chou, Chang Jen Huang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Severe acute respiratory syndrome (SARS), a new disease with symptoms similar to those of atypical pneumonia, raised a global alert in March 2003. Because of its relatively high transmissibility and mortality upon infection, probable SARS patients were quarantined and treated with special and intensive care. Therefore, instant and accurate laboratory confirmation of SARS-associated coronavirus (SARS-CoV) infection has become a worldwide interest. For this need, we purified recombinant proteins including the nucleocapsid (N), envelope (E), membrane (M), and truncated forms of the spike protein (S1-S7) of SARS-CoV in Escherichia coli. The six proteins N, E, M, S2, S5, and S6 were used for Western blotting (WB) to detect various immunoglobulin classes in 90 serum samples from 54 probable SARS patients. The results indicated that N was recognized in most of the sera. In some cases, S6 could be recognized as early as 2 or 3 days after illness onset, while S5 was recognized at a later stage. Furthermore, the result of recombinant-protein-based WB showed a 90% agreement with that of the whole-virus-based immunofluorescence assay. Combining WB with existing RT-PCR, the laboratory confirmation for SARS-CoV infection was greatly enhanced by 24.1%, from 48.1% (RT-PCR alone) to 72.2%. Finally, our results show that IgA antibodies against SARS-CoV can be detected within 1 week after illness onset in a few SARS patients.

Original languageEnglish
Pages (from-to)117-126
Number of pages10
JournalJournal of Biomedical Science
Volume11
Issue number1
DOIs
Publication statusPublished - 2004

Fingerprint

Severe Acute Respiratory Syndrome
Coronavirus
Recombinant Proteins
Nucleocapsid
Antibodies
Immunoglobulin Isotypes
Viruses
Immunoglobulin A
Escherichia coli
Assays
Proteins
Membranes
S 6
Western Blotting
Infection
ethyl-2-methylthio-4-methyl-5-pyrimidine carboxylate
Polymerase Chain Reaction
Sick Leave
Critical Care
Serum

Keywords

  • Antibody response
  • Recombinant proteins
  • SARS-CoV infection
  • Western blotting

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. / Wu, Ho Sheng; Hsieh, Yueh Chun; Su, Ih Jen; Lin, Ting Hsiang; Chiu, Shu Chun; Hsu, Yu Fen; Lin, Jih Hui; Wang, Mei Ching; Chen, Jeou Yuan; Hsiao, Pei Wen; Chang, Geen Dong; Wang, Andrew H J; Ting, Hsien Wei; Chou, Chih Ming; Huang, Chang Jen.

In: Journal of Biomedical Science, Vol. 11, No. 1, 2004, p. 117-126.

Research output: Contribution to journalArticle

Wu, HS, Hsieh, YC, Su, IJ, Lin, TH, Chiu, SC, Hsu, YF, Lin, JH, Wang, MC, Chen, JY, Hsiao, PW, Chang, GD, Wang, AHJ, Ting, HW, Chou, CM & Huang, CJ 2004, 'Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients', Journal of Biomedical Science, vol. 11, no. 1, pp. 117-126. https://doi.org/10.1159/000075294
Wu, Ho Sheng ; Hsieh, Yueh Chun ; Su, Ih Jen ; Lin, Ting Hsiang ; Chiu, Shu Chun ; Hsu, Yu Fen ; Lin, Jih Hui ; Wang, Mei Ching ; Chen, Jeou Yuan ; Hsiao, Pei Wen ; Chang, Geen Dong ; Wang, Andrew H J ; Ting, Hsien Wei ; Chou, Chih Ming ; Huang, Chang Jen. / Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. In: Journal of Biomedical Science. 2004 ; Vol. 11, No. 1. pp. 117-126.
@article{ed60b12d5e6947bda617da191619bd38,
title = "Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients",
abstract = "Severe acute respiratory syndrome (SARS), a new disease with symptoms similar to those of atypical pneumonia, raised a global alert in March 2003. Because of its relatively high transmissibility and mortality upon infection, probable SARS patients were quarantined and treated with special and intensive care. Therefore, instant and accurate laboratory confirmation of SARS-associated coronavirus (SARS-CoV) infection has become a worldwide interest. For this need, we purified recombinant proteins including the nucleocapsid (N), envelope (E), membrane (M), and truncated forms of the spike protein (S1-S7) of SARS-CoV in Escherichia coli. The six proteins N, E, M, S2, S5, and S6 were used for Western blotting (WB) to detect various immunoglobulin classes in 90 serum samples from 54 probable SARS patients. The results indicated that N was recognized in most of the sera. In some cases, S6 could be recognized as early as 2 or 3 days after illness onset, while S5 was recognized at a later stage. Furthermore, the result of recombinant-protein-based WB showed a 90{\%} agreement with that of the whole-virus-based immunofluorescence assay. Combining WB with existing RT-PCR, the laboratory confirmation for SARS-CoV infection was greatly enhanced by 24.1{\%}, from 48.1{\%} (RT-PCR alone) to 72.2{\%}. Finally, our results show that IgA antibodies against SARS-CoV can be detected within 1 week after illness onset in a few SARS patients.",
keywords = "Antibody response, Recombinant proteins, SARS-CoV infection, Western blotting",
author = "Wu, {Ho Sheng} and Hsieh, {Yueh Chun} and Su, {Ih Jen} and Lin, {Ting Hsiang} and Chiu, {Shu Chun} and Hsu, {Yu Fen} and Lin, {Jih Hui} and Wang, {Mei Ching} and Chen, {Jeou Yuan} and Hsiao, {Pei Wen} and Chang, {Geen Dong} and Wang, {Andrew H J} and Ting, {Hsien Wei} and Chou, {Chih Ming} and Huang, {Chang Jen}",
year = "2004",
doi = "10.1159/000075294",
language = "English",
volume = "11",
pages = "117--126",
journal = "Journal of Biomedical Science",
issn = "1021-7770",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients

AU - Wu, Ho Sheng

AU - Hsieh, Yueh Chun

AU - Su, Ih Jen

AU - Lin, Ting Hsiang

AU - Chiu, Shu Chun

AU - Hsu, Yu Fen

AU - Lin, Jih Hui

AU - Wang, Mei Ching

AU - Chen, Jeou Yuan

AU - Hsiao, Pei Wen

AU - Chang, Geen Dong

AU - Wang, Andrew H J

AU - Ting, Hsien Wei

AU - Chou, Chih Ming

AU - Huang, Chang Jen

PY - 2004

Y1 - 2004

N2 - Severe acute respiratory syndrome (SARS), a new disease with symptoms similar to those of atypical pneumonia, raised a global alert in March 2003. Because of its relatively high transmissibility and mortality upon infection, probable SARS patients were quarantined and treated with special and intensive care. Therefore, instant and accurate laboratory confirmation of SARS-associated coronavirus (SARS-CoV) infection has become a worldwide interest. For this need, we purified recombinant proteins including the nucleocapsid (N), envelope (E), membrane (M), and truncated forms of the spike protein (S1-S7) of SARS-CoV in Escherichia coli. The six proteins N, E, M, S2, S5, and S6 were used for Western blotting (WB) to detect various immunoglobulin classes in 90 serum samples from 54 probable SARS patients. The results indicated that N was recognized in most of the sera. In some cases, S6 could be recognized as early as 2 or 3 days after illness onset, while S5 was recognized at a later stage. Furthermore, the result of recombinant-protein-based WB showed a 90% agreement with that of the whole-virus-based immunofluorescence assay. Combining WB with existing RT-PCR, the laboratory confirmation for SARS-CoV infection was greatly enhanced by 24.1%, from 48.1% (RT-PCR alone) to 72.2%. Finally, our results show that IgA antibodies against SARS-CoV can be detected within 1 week after illness onset in a few SARS patients.

AB - Severe acute respiratory syndrome (SARS), a new disease with symptoms similar to those of atypical pneumonia, raised a global alert in March 2003. Because of its relatively high transmissibility and mortality upon infection, probable SARS patients were quarantined and treated with special and intensive care. Therefore, instant and accurate laboratory confirmation of SARS-associated coronavirus (SARS-CoV) infection has become a worldwide interest. For this need, we purified recombinant proteins including the nucleocapsid (N), envelope (E), membrane (M), and truncated forms of the spike protein (S1-S7) of SARS-CoV in Escherichia coli. The six proteins N, E, M, S2, S5, and S6 were used for Western blotting (WB) to detect various immunoglobulin classes in 90 serum samples from 54 probable SARS patients. The results indicated that N was recognized in most of the sera. In some cases, S6 could be recognized as early as 2 or 3 days after illness onset, while S5 was recognized at a later stage. Furthermore, the result of recombinant-protein-based WB showed a 90% agreement with that of the whole-virus-based immunofluorescence assay. Combining WB with existing RT-PCR, the laboratory confirmation for SARS-CoV infection was greatly enhanced by 24.1%, from 48.1% (RT-PCR alone) to 72.2%. Finally, our results show that IgA antibodies against SARS-CoV can be detected within 1 week after illness onset in a few SARS patients.

KW - Antibody response

KW - Recombinant proteins

KW - SARS-CoV infection

KW - Western blotting

UR - http://www.scopus.com/inward/record.url?scp=0842343388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842343388&partnerID=8YFLogxK

U2 - 10.1159/000075294

DO - 10.1159/000075294

M3 - Article

VL - 11

SP - 117

EP - 126

JO - Journal of Biomedical Science

JF - Journal of Biomedical Science

SN - 1021-7770

IS - 1

ER -